Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Apr;38(4):637–640. doi: 10.1128/aac.38.4.637

Tetracycline analogs whose primary target is not the bacterial ribosome.

I Chopra 1
PMCID: PMC284517  PMID: 8031024

Full text

PDF
637

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakhtiar M., Selwyn S. Antibacterial activity of a new thiatetracycline. J Antimicrob Chemother. 1983 Mar;11(3):291–291. doi: 10.1093/jac/11.3.291. [DOI] [PubMed] [Google Scholar]
  2. Burdett V., Inamine J., Rajagopalan S. Heterogeneity of tetracycline resistance determinants in Streptococcus. J Bacteriol. 1982 Mar;149(3):995–1004. doi: 10.1128/jb.149.3.995-1004.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chabbert Y. A., Scavizzi M. R. Chelocardin-inducible resistance in Escherichia coli bearing R plasmids. Antimicrob Agents Chemother. 1976 Jan;9(1):36–41. doi: 10.1128/aac.9.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chopra I., Hawkey P. M., Hinton M. Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother. 1992 Mar;29(3):245–277. doi: 10.1093/jac/29.3.245. [DOI] [PubMed] [Google Scholar]
  5. Mendez B., Tachibana C., Levy S. B. Heterogeneity of tetracycline resistance determinants. Plasmid. 1980 Mar;3(2):99–108. doi: 10.1016/0147-619x(80)90101-8. [DOI] [PubMed] [Google Scholar]
  6. Oliva B., Chopra I. Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Antimicrob Agents Chemother. 1992 Apr;36(4):876–878. doi: 10.1128/aac.36.4.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Oliva B., Gordon G., McNicholas P., Ellestad G., Chopra I. Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother. 1992 May;36(5):913–919. doi: 10.1128/aac.36.5.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Proctor R., Craig W., Kunin C. Cetocycline, tetracycline analog: in vitro studies of antimicrobial activity, serum binding, lipid solubility, and uptake by bacteria. Antimicrob Agents Chemother. 1978 Apr;13(4):598–604. doi: 10.1128/aac.13.4.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rasmussen B., Noller H. F., Daubresse G., Oliva B., Misulovin Z., Rothstein D. M., Ellestad G. A., Gluzman Y., Tally F. P., Chopra I. Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother. 1991 Nov;35(11):2306–2311. doi: 10.1128/aac.35.11.2306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Russell A. D., Ahonkhai I. Antibacterial activity of a new thiatetracycline antibiotic, thiacycline, in comparison with tetracycline, doxycycline and minocycline. J Antimicrob Chemother. 1982 Jun;9(6):445–449. doi: 10.1093/jac/9.6.445. [DOI] [PubMed] [Google Scholar]
  11. Stern S., Moazed D., Noller H. F. Structural analysis of RNA using chemical and enzymatic probing monitored by primer extension. Methods Enzymol. 1988;164:481–489. doi: 10.1016/s0076-6879(88)64064-x. [DOI] [PubMed] [Google Scholar]
  12. Testa R. T., Petersen P. J., Jacobus N. V., Sum P. E., Lee V. J., Tally F. P. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines. Antimicrob Agents Chemother. 1993 Nov;37(11):2270–2277. doi: 10.1128/aac.37.11.2270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Traub B., Beck C. F. Resistance to various tetracyclines mediated by transposon Tn10 in Escherichia coli K-12. Antimicrob Agents Chemother. 1985 May;27(5):879–881. doi: 10.1128/aac.27.5.879. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES